Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 1-2, 2006, Pages 152-158

  Davidoff, Amy J ^a  

^a UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Ca2+ regulation; Diabetic cardiomyopathy; Excitation contraction coupling; Fatty acids; Glucose; Glycosylation; Hexosamine biosynthesis; Insulin resistance; Sarco(endo)plasmic reticulum Ca2+ ATPase

Indexed keywords

FATTY ACID; HEXOSAMINE; INSULIN; SERINE; THREONINE; URIDINE DIPHOSPHATE;

AMINO ACID SUBSTITUTION; CARDIOMYOPATHY; CELL CULTURE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; GLUCOSE TRANSPORT; GLYCOSYLATION; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE EXCITABILITY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; POLYAMINE SYNTHESIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CALCIUM; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; GLUCOSE; GLYCOSYLATION; HEXOSAMINES; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 33645074682     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04343.x     Document Type: Conference Paper

References (77)

1. Zimmet P Alberti MM Shaw J Global and societal implications of the diabetes epidemic Nature 2001 414 782 7
2. Steinberger J Daniels SR Obesity, insulin resistance, diabetes, and cardiovascular risk in children Circulation 2003 107 1448 53
3. Grundy SM Benjamin IJ Burke GL et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association Circulation 1999 100 1134 46
4. Zarich SW Nesto RW Diabetic cardiomyopathy Am. Heart J. 1989 118 1000 12
5. Gargiulo P Jacobellis G Vaccari V Andreani D Diabetic cardiomyopathy: Pathophysiological and clinical aspects Diabetes NutrMetab 1998 11 336 46
6. Ritchie RH Delbridge LMD Cardiac hypertrophy, substrate utilization and metabolic remodelling: Cause or effect? Clin. Exp. Pharmacol. Physiol. 2006 33 160 7
7. Brownlee M Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 813 20
8. Hool LC Reactive oxygen species in cardiac signalling: From mitochondria to plasma membrane ion channels Clin. Exp. Pharmacol. Physiol. 2006 33 147-52
9. 2+ in the heart during diabetes CardiovascRes 1997 34 41 7
10. Taegtmeyer H McNulty P Young M Adaptation and maladaptation of the heart in diabetes. Part I: General concepts Circulation 2002 105 1727 33
11. Schaffer SW Mozafferi M Abnormal mechanical function in diabetes: Relation to myocardial calcium handling CoronArtery Dis 1996 7 109 15
12. + currents in rat heart: Role of insulin JPhysiol 1998 507 485 96
13. Abe T Ohga Y Tabayashi N et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats AmJPhysiolHeart CircPhysiol 2002 282 H138 H148
14. Wold LE Dutta K Mason MM et al. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin-resistant rats JMolCell. Cardiol 2005 39 297 307
15. 2+-dependent ATPase activity in cardiac myofibrils from the insulin-resistant JCR : LA-cp rat AdvExpMedBiol 2001 498 247 52
16. Chatham JC Seymour A-ML Cardiac carbohydrate metabolism in Zucker diabetic fatty rats CardiovascRes 2002 55 104 12
17. Okayama H Hamada M Hiwada K Contractile dysfunction in the diabetic-rat heart is an intrinsic abnormality of the cardiac myocyte ClinSci 1994 86 257 62
18. 2+ handling in ventricular myocytes isolated from diabetic rats AmJPhysiolHeart CircPhysiol 1996 270 H1529 37
19. Ren J Davidoff AJ Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes AmJPhysiolHeart CircPhysiol 1997 272 H148 58
20. Chattou S Diacono J Feuvray D Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes Acta PhysiolScand 1999 166 137 44
21. 2+ overload JPhysiol 2000 527 85 94
22. i responses to isoproterenol and cAMP in isolated cardiomyocytes from experimental diabetic rats AmJPhysiolHeart CircPhysiol 1994 266 H2334 42
23. Gando S Hattori Y Akaishi Y Nishihira J Kanno M Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: Alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation J. Pharmacol. Exp. Ther. 1997 282 475 84
24. 2+] and pH in rat skinned cardiac myocytes AmJPhysiolHeart CircPhysiol 1995 269 H1656 63
25. 2+ handling in streptozotocin-induced diabetic rat myocardium AmJPhysiolHeart CircPhysiol 1999 277 H2185 94
26. Zhong Y Ahmed S Grupp IL Matlib MA Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts AmJPhysiolHeart CircPhysiol 2001 281 H1137 47
27. Malhotra A Kang BPS Opawumi D Belizaire W Meggs LG Molecular biology of protein kinase C signaling in cardiac myocytes MolCellBiochem 2001 225 97 107
28. + currents in rat ventricular myocytes CircRes 1994 74 620 8
29. Ren J Gintant GA Miller RE Davidoff AJ High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner AmJPhysiolHeart CircPhysiol 1997 273 H2876 83
30. Davidoff AJ Ren J Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes AmJPhysiolHeart CircPhysiol 1997 272 H159 67
31. Davidoff AJ Davidson MB Carmody MW Davis M-E Ren J Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: Role of glucose-induced PKC activity MolCell. Biochem 2004 262 155 63
32. Dutta K Carmody MW Cala SE Davidoff AJ Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy JMolCell Cardiol 2002 34 985 96
33. Davidoff AJ Mason MM Davidson MB et al. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments AmJPhysiolEndocrinolMetab 2004 286 E718 24
34. Abel ED Myocardial insulin resistance and cardiac complications of diabetes CurrDrug Targets Immune EndocrMetabolDisord 2005 5 219 26
35. Kolter T Uphues I Eckel J Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats AmJPhysiolEndocrinolMetab 1997 273 E59 E67
36. Laviola L Belsanti G Davalli AM et al. Effects of streptozotocin diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart Diabetes 2001 50 2709 20
37. Zierath JR Wallberg-Henriksson H From receptor to effector: Insulin signal transduction in skeletal muscle from type II diabetic patients AnnNYAcadSci 2002 967 120 34
38. Kessler A Uphues D Ouwens M Till M Eckel J Diversification of cardiac insulin signaling involves the p85α/β subunits of phosphatidylinositol 3-kinase AmJPhysiolEndocrinolMetab 2001 280 E65 74
39. Kupriyanova TA Kandror KV Akt-2 binds to Glut-4 containing vesicles and phosphorylates their component proteins in response to insulin JBiolChem 1999 274 1458 64
40. Gual P Le Marchand-Brustel Y Tanti JF Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 2005 87 99 109
41. De Luca JP Garnache AK Rulfs J Miller TB Wortmannin inhibits insulin-stimulated activation of protein phosphatase 1 in rat cardiomyocytes AmJPhysiolHeart CircPhysiol 1999 45 H1520 26
42. Arias EB Kim J Cartee GD Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle Diabetes 2004 53 921 30
43. McClain DA Crook ED Hexosamines and insulin resistance Diabetes 1996 45 1003 9
44. Ren J Duan J Hintz KK Ren BH High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: Role of Akt and ERK activation CardiovascRes 2003 57 738 48
45. Shimoni Y Chuang M Abel ED Severson DL Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice JPhysiol 2003 555 345 54
46. Hunnicutt JW Hardy RW Williford J McDonald JM Saturated fatty acid-induced insulin resistance in rat adipocytes Diabetes 1994 43 540 5
47. Manco M Mingrone G Greco AV et al. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides Metabolism 2000 49 220 4
48. Terruzzi I Allibardi S Bendinelli P et al. Amino acid- and lipid-induced insulin resistance in rat heart: Molecular mechanisms MolCell. Endocrinol 2002 190 135 45
49. Soltys CM Buchholz L Gandhi M Clanachan AS Walsh K Dyck JRB Phosphorylation of cardiac protein kinase B is regulated by palmitate AmJPhysiolHeart CircPhysiol 2002 283 H1056 64
50. Kim JK Fillmore JJ Sunshine MJ et al. PKC-θ knockout mice are protected from fat-induced insulin resistance JClinInvest 2004 114 823 7
51. Whelan SA Hart GW Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation CircRes 2003 93 1047 58
52. Marshall S Bacote V Traxinger RR Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system JBiolChem 1991 266 4706 12
53. Cooksey RC McClain DA Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance AnnNYAcadSci 2002 967 102 11
54. Roden M Price T Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans JClinInvest 1996 97 2859 65
55. Hawkins M Barzilai N Liu R Hu M Chen W Rossetti L Role of the glucosamine pathway in fat-induced insulin resistance JClinInvest 1997 99 2173 2
56. Weigert C Klopfer K Kausch C et al. Palmitate-induced activation of the hexosamine pathway in human myotubes: Increased expression of glutamine : fructose-6-phosphate aminotransferase Diabetes 2003 52 650 6
57. Slawson C Hart GW Dynamic interplay between O-GlcNAc and O-phosphate: The sweet side of protein regulation CurrOpinStructBiol 2003 13 631 6
58. Patti M-E Antti V Landaker EJ Kahn CR Yki-Järvinen H Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin-signaling events in skeletal muscle Diabetes 1999 48 1562 71
59. Federici M Menghini R Mauriello A et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells Circulation 2002 106 466 72
60. Du XL Edelstein D Dimmeler S Ju Q Sui C Brownlee M Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site JClinInvest 2001 108 1341 8
61. Vosseller K Wells L Lane MD Hart GW Elevated nucleocytoplasmic glycosylation of O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes Proc. Natl Acad. Sci. USA 2002 99 5313 18
62. Konrad RJ Kudlow JE The role of O-linked protein glycosylation in β-cell dysfunction IntJMolMed 2002 10 535 9
63. Clark RJ McDonough PM Swanson E et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte cycling through increased nuclear O-GlcNAcylation JBiolChem 2003 278 44 230 7
64. Pang Y Bounelis P Chatham JC Marchase RB Hexosamine pathway is responsible for inhibition by diabetes of phenylephrine-induced inotropy Diabetes 2004 53 1074 81
65. Pang Y Hunton DL Bounelis P Marchase RB Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes Diabetes 2002 51 3461 7
66. Zachara NE O'Donnell N Cheung WD Mercer JJ Marth JD Hart GW Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells JBiolChem 2004 279 30 133 42
67. 2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc Am. J. Physiol. Cell Physiol 2005 in press
68. Hu Y Belke D Suarez J et al. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart CircRes 2005 96 1006 13
69. Farese RV Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states AmJPhysiolEndocrinolMetab 2002 283 E1 11
70. Marx S Ion channel macromolecular complexes in the heart JMolCellCardiol 2003 35 37 44
71. Koya D King GL Protein kinase C activation and the development of diabetic complications Diabetes 1998 47 859 66
72. Malhotra A Kang BPS Cheung S Opawumi D Meggs LG Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I Diabetes 2001 50 1918 26
73. Yasumari K Kohno M Kano H Yokokawa K Minami M Yoshikawa J Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells CircRes 1997 81 953 62
74. Fiordaliso F Leri A Cesselli D et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death Diabetes 2001 50 2363 75
75. + currents by angiotensin and endothelin AmJPhysiolHeart CircPhysiol 2003 284 H1168 81
76. Massion PB Feron O Dessy C Balligand J-L Nitric oxide and cardiac function CircRes 2003 93 388 98
77. Goldberg HJ Whiteside CI Fantus IG The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta JBiolChem 2002 277 33 833 41